Dutch Test Spares Breast Cancer Patients Chemo

Thousands of breast cancer patients in the Netherlands could be skipping grueling chemotherapy treatments, but a promising test that makes this possible remains underused by doctors.

The test analyzes tumor cells to predict whether early-stage breast cancer will spread to other parts of the body. This information helps doctors determine if chemotherapy is truly necessary or if patients can safely skip it.

Currently, only one in three eligible women receive this assessment, according to the Dutch cancer research center IKNL. That means many patients may be enduring months of chemotherapy and its harsh side effects when they don't actually need it.

About 13% of breast cancer patients qualify for the screening. Before 2023, when health experts began actively promoting the test, only one in 10 eligible women were assessed.

The good news? The test is fully covered by health insurance, removing financial barriers. Researchers Sabine Siesling and her team at IKNL and the University of Twente are now investigating why doctors aren't ordering it more often.

Understanding this gap could transform treatment for thousands of women each year. Chemotherapy can cause fatigue, nausea, hair loss, and long-term health complications. Avoiding unnecessary treatment means patients can maintain their quality of life while still receiving the care they need.

The Bright Side

The fact that this test exists at all represents a major leap forward in personalized cancer care. Just a few years ago, doctors had no reliable way to predict which early-stage cancers would remain localized and which would spread.

Now medical science can analyze tumors at the molecular level, sparing patients from overtreatment while ensuring those who need aggressive therapy still receive it. The challenge isn't the technology anymore but making sure every eligible patient benefits from it.

The sharp increase in testing rates from 10% before 2023 to 33% today shows progress is possible when the medical community focuses on a problem. Researchers are optimistic that identifying specific barriers, whether they're related to awareness, training, or hospital protocols, will help close the remaining gap.

Every woman who avoids unnecessary chemotherapy gets to spend more time feeling healthy, working, caring for family, and living fully during a challenging period.